Furthermore, intratumoral administration of CeO2NPs-MSA resulted in a clear enhancement of contrast signal in the tumour, which remained enhanced for the entire 7-day observation period and the long residence times of the contrast agent allowed for observing structural changes in the tumour over time. The gene discussed is TPO; the disease is neoplasm.